OPHTHALMIC COMPOSITION
OPHTHALMIC COMPOSITION The present invention addresses the problem of maintaining a high retention rate of the kinematic viscosity of an ophthalmic composition, such as an ophthalmic solution comprising hyaluronic acid or a salt thereof. Provided is an ophthalmic composition comprising 0.001-0.5% (w...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | OHNO, Takanori KAWAHATA, Masahiro |
description | OPHTHALMIC COMPOSITION The present invention addresses the problem of maintaining a high retention rate of the kinematic viscosity of an ophthalmic composition, such as an ophthalmic solution comprising hyaluronic acid or a salt thereof. Provided is an ophthalmic composition comprising 0.001-0.5% (w/v) of hyaluronic acid or a salt thereof, 0.0005-0.02% (w/v) of chlorhexidines, 0.03-1.5% (w/v) of propylene glycol, and 0.015% (w/v) or less of ethylenediaminetetraacetates. (No Suitable Figure) |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SG10201901426WA</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SG10201901426WA</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SG10201901426WA3</originalsourceid><addsrcrecordid>eNrjZBDzD_AI8XD08fV0VnD29w3wD_YM8fT342FgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8cHuhgZGBoaWBoYmRmbhjsZEKgMAh4gg1A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>OPHTHALMIC COMPOSITION</title><source>esp@cenet</source><creator>OHNO, Takanori ; KAWAHATA, Masahiro</creator><creatorcontrib>OHNO, Takanori ; KAWAHATA, Masahiro</creatorcontrib><description>OPHTHALMIC COMPOSITION The present invention addresses the problem of maintaining a high retention rate of the kinematic viscosity of an ophthalmic composition, such as an ophthalmic solution comprising hyaluronic acid or a salt thereof. Provided is an ophthalmic composition comprising 0.001-0.5% (w/v) of hyaluronic acid or a salt thereof, 0.0005-0.02% (w/v) of chlorhexidines, 0.03-1.5% (w/v) of propylene glycol, and 0.015% (w/v) or less of ethylenediaminetetraacetates. (No Suitable Figure)</description><language>eng</language><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190328&DB=EPODOC&CC=SG&NR=10201901426WA$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190328&DB=EPODOC&CC=SG&NR=10201901426WA$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OHNO, Takanori</creatorcontrib><creatorcontrib>KAWAHATA, Masahiro</creatorcontrib><title>OPHTHALMIC COMPOSITION</title><description>OPHTHALMIC COMPOSITION The present invention addresses the problem of maintaining a high retention rate of the kinematic viscosity of an ophthalmic composition, such as an ophthalmic solution comprising hyaluronic acid or a salt thereof. Provided is an ophthalmic composition comprising 0.001-0.5% (w/v) of hyaluronic acid or a salt thereof, 0.0005-0.02% (w/v) of chlorhexidines, 0.03-1.5% (w/v) of propylene glycol, and 0.015% (w/v) or less of ethylenediaminetetraacetates. (No Suitable Figure)</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBDzD_AI8XD08fV0VnD29w3wD_YM8fT342FgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8cHuhgZGBoaWBoYmRmbhjsZEKgMAh4gg1A</recordid><startdate>20190328</startdate><enddate>20190328</enddate><creator>OHNO, Takanori</creator><creator>KAWAHATA, Masahiro</creator><scope>EVB</scope></search><sort><creationdate>20190328</creationdate><title>OPHTHALMIC COMPOSITION</title><author>OHNO, Takanori ; KAWAHATA, Masahiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SG10201901426WA3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>online_resources</toplevel><creatorcontrib>OHNO, Takanori</creatorcontrib><creatorcontrib>KAWAHATA, Masahiro</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OHNO, Takanori</au><au>KAWAHATA, Masahiro</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>OPHTHALMIC COMPOSITION</title><date>2019-03-28</date><risdate>2019</risdate><abstract>OPHTHALMIC COMPOSITION The present invention addresses the problem of maintaining a high retention rate of the kinematic viscosity of an ophthalmic composition, such as an ophthalmic solution comprising hyaluronic acid or a salt thereof. Provided is an ophthalmic composition comprising 0.001-0.5% (w/v) of hyaluronic acid or a salt thereof, 0.0005-0.02% (w/v) of chlorhexidines, 0.03-1.5% (w/v) of propylene glycol, and 0.015% (w/v) or less of ethylenediaminetetraacetates. (No Suitable Figure)</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_SG10201901426WA |
source | esp@cenet |
title | OPHTHALMIC COMPOSITION |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T21%3A40%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OHNO,%20Takanori&rft.date=2019-03-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESG10201901426WA%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |